• Home
  • Study Details
COM_RESEARCHSTUDIES_DETAIL_AVAL_STATUS_4

CIVO Intratumoral Microdosing of Anti-Cancer Therapies (Phase 0)

In this study, we want to learn more about the effects of different anti-cancer therapies by intramural administration. This study is for people with head and neck cancer or soft tissue sarcoma who are planning to have surgery to remove their tumor.

Age & Gender

  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive

Contact the Team

Location

COM_RESEARCHSTUDIES_DETAIL_HEADER_BASIC_CONTACT_4

United States (Nationwide)

Additional Study Information

Principal Investigator

Sid Sheth
LCCC - Clinical Trials

Study Type

Clinical or Medical
Interventional

Study Topics

Cancer (Breast, Head and Neck, Melanoma, Sarcoma (bone and soft tissue), Phase 1 Trials (all cancers), Lymphoma)

IRB Number

22-2514

ClinicalTrials.gov

NCT04541108

Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research